A Look Into Two Years of Open Payments Data and its Media Coverage

With three years’ worth of Open Payments data made publicly available by CMS, trial lawyers are putting in their best to mine all that transparency data and pull out questionable transactions to bring new health care fraud cases to light. Apart from that, the media is also working hard to highlight these cases, which deems it necessary for pharma companies to be all the more careful when documenting their spend data.

In this interesting presentation, Thomas Sullivan, Publisher, Life Science Compliance Update, provides a detailed review of the 2014-2015 Open Payments Data, an evaluation of persecutions and an extensive assessment of the congressional actions on Open Payments. It moves on to providing details about the ways in which Open Payments data is being evaluated by the media along with other tied in spend reports to find and highlight data anomalies.